Dynamic Technology Lab Private Ltd Sells 9,939 Shares of Zoetis Inc. $ZTS

Dynamic Technology Lab Private Ltd lessened its stake in Zoetis Inc. (NYSE:ZTS) by 85.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,711 shares of the company’s stock after selling 9,939 shares during the quarter. Dynamic Technology Lab Private Ltd’s holdings in Zoetis were worth $250,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently bought and sold shares of ZTS. North Star Asset Management Inc. increased its stake in Zoetis by 4.9% during the 2nd quarter. North Star Asset Management Inc. now owns 1,441 shares of the company’s stock valued at $225,000 after purchasing an additional 67 shares in the last quarter. Bank of Nova Scotia Trust Co. lifted its stake in shares of Zoetis by 4.6% in the second quarter. Bank of Nova Scotia Trust Co. now owns 1,692 shares of the company’s stock worth $264,000 after buying an additional 74 shares in the last quarter. Summit Place Financial Advisors LLC grew its holdings in shares of Zoetis by 0.4% during the third quarter. Summit Place Financial Advisors LLC now owns 19,369 shares of the company’s stock valued at $2,834,000 after buying an additional 76 shares during the last quarter. First County Bank CT increased its position in shares of Zoetis by 5.4% during the third quarter. First County Bank CT now owns 1,535 shares of the company’s stock valued at $225,000 after acquiring an additional 79 shares in the last quarter. Finally, CWA Asset Management Group LLC raised its holdings in Zoetis by 1.1% in the 3rd quarter. CWA Asset Management Group LLC now owns 7,236 shares of the company’s stock worth $1,059,000 after acquiring an additional 80 shares during the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ZTS has been the topic of several recent analyst reports. BTIG Research reiterated a “buy” rating and set a $160.00 target price on shares of Zoetis in a research note on Thursday, February 26th. Wall Street Zen raised Zoetis from a “hold” rating to a “buy” rating in a research report on Saturday, February 21st. The Goldman Sachs Group upgraded Zoetis to a “buy” rating in a report on Monday, December 15th. UBS Group set a $136.00 price target on shares of Zoetis in a report on Thursday, January 29th. Finally, Piper Sandler reissued a “neutral” rating and set a $135.00 price objective (down from $190.00) on shares of Zoetis in a report on Thursday, January 22nd. Six research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $152.91.

Zoetis Stock Down 3.8%

ZTS stock opened at $115.25 on Friday. The company has a market cap of $48.65 billion, a price-to-earnings ratio of 19.14, a P/E/G ratio of 1.83 and a beta of 0.95. The company has a debt-to-equity ratio of 2.71, a quick ratio of 1.94 and a current ratio of 3.03. The business’s 50-day moving average is $125.54 and its two-hundred day moving average is $132.19. Zoetis Inc. has a fifty-two week low of $115.23 and a fifty-two week high of $172.23.

Zoetis (NYSE:ZTS) last released its quarterly earnings results on Thursday, February 12th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.08. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The business had revenue of $2.39 billion during the quarter, compared to the consensus estimate of $2.36 billion. During the same period in the previous year, the company posted $1.40 EPS. The business’s quarterly revenue was up 3.0% compared to the same quarter last year. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. As a group, analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 2nd. Shareholders of record on Monday, April 20th will be issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis’s dividend payout ratio is currently 35.22%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.